By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Integrated Diagnostics, which is using genomics and proteomics technologies to develop molecular diagnostics tests, announced today it has raised $10 million in a second tranche of its Series A financing round.

Investors in the round include new investor, BioTechCube Luxembourg, a newly formed investment company, and existing investors InterWest Partners and Wellcome Trust, a spokesman said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.